[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1946

THYROXIN THERAPY IN OTOSCLEROSIS

Arch Otolaryngol. 1946;44(1):43-50. doi:10.1001/archotol.1946.00680060054004
Abstract

THIS report summarizes the effects of thyroxin therapy as observed in 64 patients presenting clinical evidence of otosclerosis. Of these, 32 patients were treated according to the technic of Gray, while in 32 additional patients a different local anesthetic and a different preparation of thyroxin were employed for purposes of comparison.

The hypothesis that "the essential causative factor of otosclerosis is a gradually increasing defect in the vasomotor mechanism which governs the nutrition of the structures of the organ of hearing as a whole" was advanced by the late Albert A. Gray in 1934.1 In his ingenious and convincing presentation it was pointed out that since the axon reflexes were included in the vasomotor mechanism and since the stimulus exciting the vasomotor mechanism was sound alone, it followed that the vestibular apparatus and the semicircular canals would be unaffected in otosclerosis. The deafness of persons with otosclerosis was regarded as

×